SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVR - Bulls no Bears

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: garden_man who wrote (838)9/30/1997 11:54:00 PM
From: Kingfisher   of 913
 
Joe, I fully agree that a significant increase in volume has to occur in conjunction with an upward
price movement to mean that good information is forthcoming. The only thing I can say about
2-3 million shares a day is that it would be nice but you might not need that many shares a day to
see a nice price movement. I feel that with the stock staying in the low $0.20s for a significant
period of time, there has been sufficient time for the common folk investors to accumulate stock,
just like the market makers [an possible takeover entities]. Thus, I feel the supply of stock is
getting kind of thin at these low prices.

I have been trying to point out in my resent Posts that because of the compelling evidence
concerning Reticulose's effectiveness against VIRAL infection and CANCER, the FDA has no
choice but to approve Reticulose soon. The FDA, through the NIH/NCI, has the information in
hand for approval and it is just illogical to think that Reticulose should not be approved. We are
out of the scientific substantiation phase and if we continue to see delay on the part of the FDA it is
because we have entered the nasty political phase.

I have been pondering over the thought that the scientific evidence regarding Reticulose is in and
that the fight is essentially over. Therefore, I intend to, once again, write my state Senators and
Congressman and let them know that the FDA is continuing to delay approval of Reticulose even
after they knew during May-to-Sept 1966 that Dr. Hirschman's findings showed Reticulose can be
used to treat CANCER. I intend to tell them the following, which is essentially what I have posted
on this and the other ADVR Thread.

Reticulose has been found to stimulate the immune system to make TUMOR NECROSIS
FACTOR and GAMMA INTERFERON. The TUMOR NECROSIS FACTOR kills and shrinks
the CANCER and the GAMMA INTERFERON strengths the cell wall to resist infection. Thus,
Reticulose has been shown to have a two prong approach in dealing with CANCER, one
offensive, where the IMMUNE SYSTEM ATTACKS AND KILLS THE CANCER and the other
defensive where the BODY IS STIMULATED TO RESIST INFECTION. And to top all of this,
Reticulose is a naturally derived compound and is non toxic [no side effects].

I've left my representatives alone for some time now [3-4 years] and I think we have reach a point
in time that we should let them know what is going on. Maybe we can light a fire under there
asses and get the Senate FDA oversight committee to specifically question the FDA about Reticulose.
Unfortunately, the three times I've written my Senators and Representative in the past was not at
all successful in getting them to question the FDA about Reticulose, even with one of them sitting
on the Senate oversight committee.

Oh well! "If at first you don't succeed, try, try again" (12,000,000 BC)

The Kingfisher
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext